Evidence map›Paper›PMID 28407397›Full record

ArticleHuman mutation2017

Whole-protein alanine-scanning mutagenesis of allostery: A large percentage of a protein can contribute to mechanism.

Qingling Tang, Aron W Fenton

Open access · bronzeAbstract read
In one paragraph

Article in Human mutation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Selective control of ligand binding through a distal mutation that alters the protein native ensemble.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Dissecting the effects of single amino acid substitutions in SARS-CoV-2 Mpro.Protein science : a publication of the Protein Society · 2025
    Article
  6. Rheostatic contributions to protein stability can obscure a position's functional role.Protein science : a publication of the Protein Society · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Serendipitous Identification of a Covalent Activator of Liver Pyruvate Kinase.Chembiochem : a European journal of chemical biology · 2023
    Article
  14. Article
  15. Article
  16. High throughput and quantitative enzymology in the genomic era.Current opinion in structural biology · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Qingling TangDepartment of Biochemistry and Molecular Biology, The University of Kansas Medical Center, Kansas City, Kansas.
Aron W FentonDepartment of Biochemistry and Molecular Biology, The University of Kansas Medical Center, Kansas City, Kansas.ORCID 0000-0001-8214-4785
University of Kansas Medical Center · US

Funding

Dissecting Allostery in Pyruvate KinaseR01GM115340 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI FENTON, ARON W · 2016 to 2019
$1.4M
NIGMS NIH HHS R01 GM115340
6 · The paper itself

Abstract

Many studies of allosteric mechanisms use limited numbers of mutations to test whether residues play "key" roles. However, if a large percentage of the protein contributes to allosteric function, mutating any residue would have a high probability of modifying allostery. Thus, a predicted mechanism that is dependent on only a few residues could erroneously appear to be supported. We used whole-protein alanine-scanning mutagenesis to determine which amino acid sidechains of human liver pyruvate kinase (hL-PYK; approved symbol PKLR) contribute to regulation by fructose-1,6-bisphosphate (Fru-1,6-BP; activator) and alanine (inhibitor). Each nonalanine/nonglycine residue of hL-PYK was mutated to alanine to generate 431 mutant proteins. Allosteric functions in active proteins were quantified by following substrate affinity over a concentration range of effectors. Results show that different residues contribute to the two allosteric functions. Only a small fraction of mutated residues perturbed inhibition by alanine. In contrast, a large percentage of mutated residues influenced activation by Fru-1,6-BP; inhibition by alanine is not simply the reverse of activation by Fru-1,6-BP. Moreover, the results show that Fru-1,6-BP activation would be extremely difficult to elucidate using a limited number of mutations. Additionally, this large mutational data set will be useful to train and test computational algorithms aiming to predict allosteric mechanisms.

Indexed as

MutationAlanineAlgorithmsAllosteric RegulationComputational BiologyCrystallography, X-RayEnzyme ActivationFructosediphosphatesHumansModels, MolecularPyruvate KinaseAlaninefructose-1,6-diphosphateFructosediphosphatesPyruvate Kinasealanine-scanning mutagenesisallosteric mechanismallosteric regulationallosteryliver pyruvate kinasePKLR

Identifiers

PMID28407397
PMCPMC5561450
OpenAlexW2606362592

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.